AMEETA M MANHAS

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry DALLAS, TX NPI 1013179951

General Payments — all program years on this page

$1,342.45

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $315.67 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $315.6720

By paying entity

Latest program year (PY2020) · sorted by reported total.

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $114.819
Alkermes, Inc. $99.325
Gilead Sciences, Inc. $57.323
Otsuka America Pharmaceutical, Inc. $33.092
Indivior Inc. $11.131

By program year

Program yearAmountRecords
2018 $157.2311
2019 $869.5531
2020 $315.6720

Records — PY2020 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
718973659 Janssen Pharmaceuticals, Inc $5.84 01/08/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973667 Janssen Pharmaceuticals, Inc $4.33 01/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973672 Janssen Pharmaceuticals, Inc $11.06 01/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973679 Janssen Pharmaceuticals, Inc $18.01 02/19/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973685 Janssen Pharmaceuticals, Inc $15.80 02/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973691 Janssen Pharmaceuticals, Inc $18.19 02/11/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973699 Janssen Pharmaceuticals, Inc $9.48 02/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973705 Janssen Pharmaceuticals, Inc $13.76 01/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718973713 Janssen Pharmaceuticals, Inc $18.34 01/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736974927 Alkermes, Inc. $23.57 01/25/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736974929 Alkermes, Inc. $22.54 01/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736974931 Alkermes, Inc. $19.49 02/24/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736974933 Alkermes, Inc. $22.60 08/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736974935 Alkermes, Inc. $11.12 10/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747960877 Gilead Sciences, Inc. $19.20 02/25/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747986283 Gilead Sciences, Inc. $18.47 03/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747986285 Gilead Sciences, Inc. $19.65 07/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748750943 Otsuka America Pharmaceutical, Inc. $20.83 07/29/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
748750947 Otsuka America Pharmaceutical, Inc. $12.26 10/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
752769773 Indivior Inc. $11.13 03/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.